Trial Profile
Dibotermin-alfa as an alternative to bone graft in eldery patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Dibotermin alfa (Primary)
- Indications Bone disorders; Spinal disorders
- Focus Adverse reactions; Therapeutic Use
- 10 Dec 2015 New trial record